Suppr超能文献

经溶栓治疗失败的 ST 段抬高型心肌梗死患者行补救性经皮冠状动脉介入治疗:一项基于人群的研究。

Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: a population-based study.

机构信息

Division of Cardiology, Schulich Heart Centre, University of Toronto, Ontario, Canada.

出版信息

Am Heart J. 2011 Apr;161(4):764-770.e1. doi: 10.1016/j.ahj.2010.12.016.

Abstract

BACKGROUND

Fibrinolytic therapy remains the reperfusion strategy of choice for many regions treating patients presenting with ST-segment elevation myocardial infarction (STEMI). However, limited data exist regarding the pattern of use of rescue percutaneous coronary intervention (PCI) in patients with STEMI who failed fibrinolysis, factors associated with its use, and its impact on long-term outcomes.

METHODS

Observational analysis of a population-based cohort was done, which included 2,953 patients with STEMI hospitalized from 2004 to 2005 in Ontario, Canada. Failed fibrinolysis was defined as <50% ST-segment resolution on follow-up electrocardiogram at 60 to 90 minutes after fibrinolysis. The main outcome of measure was death or repeat hospitalization for acute coronary syndrome at 4 years.

RESULTS

Among the 1,517 patients who received fibrinolytic therapy, 611 patients (40.3%) failed fibrinolysis. Of these, rescue PCI was performed in 212 patients (34.7%); conservative management, in 373 patients (61.1%); and repeat fibrinolysis, in 26 patients (4.3%). Initial presentation to a PCI hospital was the strongest predictor of rescue PCI use (odds ratio 3.7, 95% CI 2.2-6.0). At 4-year follow-up, the primary end point occurred in 24.5% of patients who received rescue PCI and 36.5% in patients with no rescue PCI (adjusted hazard ratio 0.69, 95% CI 0.49-0.96). This difference was attributable mainly to a significant reduction in death favoring rescue PCI patients (hazard ratio 0.60, 95% CI 0.38-0.94).

CONCLUSIONS

Rescue PCI was associated with significantly lower risk of long-term adverse outcomes for patients with STEMI who failed fibrinolytic therapy. However, rescue PCI is substantially underused in clinical practice.

摘要

背景

纤溶治疗仍然是许多地区治疗 ST 段抬高型心肌梗死(STEMI)患者再灌注的首选策略。然而,对于溶栓失败的 STEMI 患者,关于补救经皮冠状动脉介入治疗(PCI)的应用模式、相关因素及其对长期预后的影响,相关数据十分有限。

方法

对 2004 年至 2005 年期间在加拿大安大略省住院的 2953 例 STEMI 患者进行了一项基于人群的观察性分析。溶栓失败定义为溶栓后 60-90 分钟时随访心电图上的 ST 段回落<50%。主要测量终点是 4 年内死亡或因急性冠状动脉综合征再次住院。

结果

在接受溶栓治疗的 1517 例患者中,有 611 例(40.3%)溶栓失败。其中,212 例(34.7%)接受补救 PCI;373 例(61.1%)接受保守治疗;26 例(4.3%)再次接受溶栓治疗。最初就诊于 PCI 医院是接受补救 PCI 治疗的最强预测因素(比值比 3.7,95%置信区间 2.2-6.0)。在 4 年随访时,接受补救 PCI 的患者中有 24.5%发生了主要终点事件,而未接受补救 PCI 的患者中有 36.5%发生了主要终点事件(校正风险比 0.69,95%置信区间 0.49-0.96)。这种差异主要归因于接受补救 PCI 的患者死亡风险显著降低(风险比 0.60,95%置信区间 0.38-0.94)。

结论

对于溶栓失败的 STEMI 患者,补救 PCI 与较低的长期不良预后风险显著相关。然而,补救 PCI 在临床实践中并未得到充分应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验